Jed Jebali | Recherche | Best Researcher Award

Prof Dr. Jed Jebali | Recherche | Best Researcher Award

Doctor, institut pasteur de tunis, Tunisia

Dr. Jed Jebali is a seasoned researcher specializing in the study of snake venoms, particularly from the vipers, at the Institut Pasteur de Tunis. With a focus on the biochemical and pharmacological properties of venom components, Dr. Jebali has contributed significantly to the understanding of their anticancer and anti-inflammatory activities. She is currently a Maître de conférences at the Institut Pasteur de Tunis.

Profile

Scopus

Evaluation of Dr. Jebali Jed for the Best Researcher Award

Strengths for the Award

  1. Academic Background and Expertise: Dr. Jebali Jed has an extensive academic background in molecular biology, with a Doctorate and Habilitation universitaire à Diriger les Travaux de Recherche (HDR). This showcases a deep level of expertise and a strong foundation in the field.
  2. Research Focus and Impact: Dr. Jebali’s research primarily focuses on the biochemical and pharmacological properties of viper venoms, specifically their anti-cancer and anti-inflammatory activities. This research has significant implications for developing novel therapeutic agents.
  3. Publication Record: Dr. Jebali has published several research papers in reputable journals, including studies on the pharmacological effects of snake venom components and their potential therapeutic applications. The inclusion of recent publications in high-impact journals like “Current Neuropharmacology” and “International Journal of Molecular Sciences” underscores the relevance and quality of the research.
  4. Professional Experience: With over a decade of experience in teaching and research, Dr. Jebali has held positions from a contract teacher to a Biologist (Maître de conférences) at the Institut Pasteur de Tunis. This progression highlights a steady career growth and recognition within the scientific community.
  5. Collaborative Projects: The involvement in collaborative research projects, as evidenced by co-authored publications with multiple researchers, demonstrates the ability to work effectively in a team and contribute to multidisciplinary research efforts.

Areas for Improvement

  1. Broader Research Dissemination: While Dr. Jebali has a solid publication record, increasing participation in international conferences and presenting research findings to a broader audience could enhance visibility and impact.
  2. H-index Improvement: An H-index of 10 is commendable, but there is potential for growth. Engaging in high-impact research projects and targeting top-tier journals can help improve this metric, reflecting wider recognition and citation of the work.
  3. Grant Acquisition: Securing more research grants and funding can amplify the scope and scale of research projects, providing additional resources for innovative studies and collaborations.
  4. Mentorship and Leadership: Developing a stronger presence in mentorship roles and leading larger research teams or departments can further establish Dr. Jebali as a leading figure in the field, fostering the next generation of researchers.

🎓 Education

  • Nov 2020: Habilitation universitaire à Diriger les Travaux de Recherche (HDR), Institut Pasteur de Tunis. Thesis: “Les lectines de type C issues de venin de la vipère Macrovipera Lebetena: activités anti tumorales et anti-inflammatoire.”
  • Sep 2012: Ph.D. in Biology, Faculty of Sciences of Tunis (FST). Dissertation: “Les lectines de type C issues de la vipère Tunisienne Macrovipera lebetina: clonage, caractérisation génétique et expression dans les cellules embryonnaires du Rein Humain.”
  • Dec 2004: Master in Molecular and Cellular Biology. Dissertation: “Analyse moléculaire de la protéine LeIF des parasites du genre Leishmania: Modélisation Moléculaire comparée et Mutagenèse par délétion.”
  • Jun 2002: Bachelor’s in Life Sciences, Faculty of Sciences of Sfax (FSS).
  • Jun 1997: Baccalaureate in Experimental Sciences.

💼 Experience

  • 2010-2014: Contractual Lecturer at the Higher Institute of Biotechnology of Beja, University of Jendouba.
  • 2012-2014: Volunteer Postdoctoral Fellow at the Institut Pasteur de Tunis.
  • Oct 2014: Appointed as an Assistant Biologist at the Laboratory of Venoms and Therapeutic Biomolecules, Institut Pasteur de Tunis.
  • Oct 2016: Permanent position as Assistant Biologist at the Institut Pasteur de Tunis.
  • Sep 2022: Promoted to Biologist (Maître de conférences) at the Laboratory of Venom Biomolecules and Theranostic Applications, Institut Pasteur de Tunis.

🔬 Research Interests

Dr. Jebali’s research focuses on the biochemical and pharmacological analysis of viper venoms, specifically their interaction with integrins and their anticancer and anti-inflammatory properties. She has a strong background in molecular biology, contributing to the expression of various venom proteins and peptides.

📚 Publications Top Notes

  1. 2023: “Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice” in Current Neuropharmacology. Read
  2. 2023: “CC5 and CC8, Two Disintegrin Isoforms from Cerastes cerastes Snake Venom Decreased Inflammation Response In Vitro and In Vivo” in International Journal of Molecular Sciences. Read
  3. 2022: “Investigation of the Renal Protective Effect of Combined Dietary Polyphenols in Streptozotocin-Induced Diabetic Aged Rats” in Nutrients. Read
  4. 2022: “Tunisian Native Mentha pulegium L. Extracts: Phytochemical Composition and Biological Activities” in Molecules. Read

📈 Cited by Articles

  • The publication on the hormetic-like effect of Lebecetin in Current Neuropharmacology has been cited by various research articles focusing on inflammation and neuropharmacology.
  • The study on disintegrin isoforms from Cerastes cerastes snake venom in International Journal of Molecular Sciences has attracted citations in the fields of molecular biology and inflammation research.
  • Research on renal protection by dietary polyphenols in Nutrients is frequently referenced in studies related to diabetes and renal health.
  • The work on Mentha pulegium L. extracts in Molecules is cited in research exploring phytochemistry and biological activities of plant extracts.

Conclusion

Dr. Jebali Jed is a strong candidate for the Best Researcher Award, with a robust academic background, impactful research focus, and a proven track record of publications and professional growth. The areas for improvement, such as increasing research dissemination, enhancing the H-index, securing more grants, and expanding mentorship roles, are achievable and would further solidify Dr. Jebali’s standing in the scientific community. Overall, Dr. Jebali’s contributions to the field of molecular biology and the study of viper venoms position them as a valuable and deserving contender for the award.

S. M. Moazzem Hossen | Natural Product | Best Researcher Award

Mr. S. M. Moazzem Hossen | Natural Product | Best Researcher Award

Associate Professor, Department of Pharmacy, University of Chittagong, Bangladesh

🏆 Mr. S. M. Moazzem Hossen, an Associate Professor at the Department of Pharmacy, University of Chittagong, Bangladesh, has been honored with the prestigious Natural Product Best Researcher Award. His exemplary dedication to research in the field of natural products has significantly contributed to advancing pharmaceutical sciences. Through his innovative studies and profound insights, Mr. Hossen has consistently demonstrated a commitment to excellence, inspiring both colleagues and students alike. This recognition underscores his remarkable achievements and underscores his invaluable contributions to academia and the broader scientific community. Mr. Hossen’s passion for discovery continues to propel advancements in natural product research, shaping the future of pharmaceutical innovation. 🌿

Profile

Google Scholar

Degree Obtained

🎓 Mr. S. M. Moazzem Hossen, currently pursuing his PhD in the Department of Applied Chemistry and Chemical Engineering at the University of Chittagong, possesses a rich academic background. He holds an M.Pharm from the University of Science and Technology Chittagong (2008), complemented by a PGT from the High-tech Institute of Pharmaceutical Technology, Hyderabad, India (2007), and a B.Pharm from Andhra University, India (2007). His educational journey began at Chittagong College for HSC in 2002 and SSC under the Chittagong Board in 1999. This comprehensive academic trajectory reflects his steadfast commitment to scholarly pursuits and lays a strong foundation for his impactful contributions to the pharmaceutical field. 📚

Field Studied

🔬 Mr. S. M. Moazzem Hossen’s expertise spans across multiple domains within the pharmaceutical realm, including Natural Product Chemistry, Pharmaceutical Technology, Biopharmaceutics, and Pharmacokinetics. His proficiency in Natural Product Chemistry enables him to explore the intricate compounds derived from nature, unlocking potential therapeutic agents. In Pharmaceutical Technology, he delves into innovative drug delivery systems and formulation techniques to enhance efficacy and patient compliance. Biopharmaceutics and Pharmacokinetics are areas where Mr. Hossen navigates the complexities of drug absorption, distribution, metabolism, and excretion, crucial for optimizing drug therapy outcomes. His multidisciplinary knowledge base underscores his versatility and effectiveness in addressing diverse challenges within the pharmaceutical industry. 💊

Research Interest

🌿 Mr. S. M. Moazzem Hossen’s expertise traverses an extensive spectrum within pharmaceutical sciences, encompassing Natural Product and Phytochemistry, Marine Biology, Drug Discovery, and Drug Design. His focus on Natural Product and Phytochemistry involves the exploration of bioactive compounds derived from plants, shedding light on their pharmacological properties and potential therapeutic applications. In the realm of Marine Biology, Mr. Hossen investigates the diverse ecosystems of marine organisms, seeking novel bioactive molecules with pharmaceutical relevance. Furthermore, his dedication to Drug Discovery and Drug Design involves utilizing cutting-edge methodologies to identify lead compounds and optimize their pharmacokinetic profiles, fostering advancements in pharmaceutical research and development. 🌊💡

Employment experience

🎓 Mr. S. M. Moazzem Hossen’s illustrious academic career spans several significant roles within the Department of Pharmacy at the University of Chittagong and the University of Science and Technology Chittagong. Commencing as a Lecturer at the latter institution in November 2008, he steadily advanced to become an Assistant Professor before transitioning to the University of Chittagong. There, he assumed the roles of Lecturer and subsequently, Assistant Professor, before attaining the esteemed position of Associate Professor in October 2023, where he continues to impart knowledge and mentor aspiring pharmacists. Notably, Mr. Hossen also served as the Chairman of the Department of Pharmacy at the University of Chittagong from April 2017 to April 2020, demonstrating his commitment to academic leadership and institutional development. 📚

Publications Top Notes

“Chemical profiles, pharmacological properties, and in silico studies provide new insights on Cycas pectinata” – cited 59 times in 2020.

“Antidepressant, anxiolytic, antipyretic, and thrombolytic profiling of methanol extract of the aerial part of Piper nigrum: In vivo, in vitro, and in silico approaches” – cited 47 times in 2021.

“In vitro studies on antibacterial and antifungal activities of Emblica officinalis” – cited 32 times in 2012.

“In vivo sedative activity of methanolic extract of Stericulia villosa Roxb. leaves” – cited 27 times in 2016.

“Anti-diarrheal, Analgesic and Anti-microbial activities of the plant Lalmesta (Hibiscus sabdariffa): A review” – cited 20 times in 2012.

“CNS anti-depressant, anxiolytic and analgesic effects of Ganoderma applanatum (mushroom) along with ligand-receptor binding screening provide new insights: Multi-disciplinary …” – cited 17 times in 2021.

“Ganoderma applanatum mushroom provides new insights into the management of diabetes mellitus, hyperlipidemia, and hepatic degeneration: A comprehensive …” – cited 17 times in 2021.

“Profiling of phytochemical and antioxidant activity of wild mushrooms: Evidence from the in vitro study and phytoconstituent’s binding affinity to the human erythrocyte …” – cited 16 times in 2022.

“Medicinal potential of Phyllanthus emblica (Linn.) fruits extracts: biological and pharmacological activities” – cited 15 times in 2014.

“Assessment of Thrombolytic Activity of Five Bangladeshi Medicinal Plants: Potential Source for Thrombolytic Compounds” – cited 15 times in 2014.